NP
Nick Pizzie
Chief Financial Officer

Nick Pizzie insider trades: Axsome Therapeutics (AXSM) stock buys and sales

Chief Financial Officer, Axsome Therapeutics Last trade Jun 9, 2026 20 Form 4 filings
$10.2M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2018
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Nick reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 9, 2026AXSM↓ Sell$7.9M
Jan 22, 2026AXSM↓ Sell$2.3M
Feb 14, 2025AXSM↓ Sell$2.0M
Nov 18, 2021AXSM↑ Buy$19K
Nov 18, 2021AXSM↑ Buy$15K
Jun 29, 2020AXSM↑ Buy$60K
Sep 26, 2019AXSM↑ Buy$54K
Jun 11, 2019AXSM↑ Buy$40K
Mar 19, 2019AXSM↑ Buy$67K
Mar 19, 2019AXSM↑ Buy$761
Jun 19, 2018AXSM↑ Buy$96K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AXSM insiders

Open-market trades in the last 12 months

About Nick Pizzie's insider trades

Nick Pizzie is Chief Financial Officer at Axsome Therapeutics (AXSM). Since Jun 19, 2018, Nick has reported 8 open-market purchases worth $351K and 3 sales worth $12.1M on SEC Form 4. In the last 12 months: 2 sales ($10.2M).

Their filings also include grants and awards (11 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AXSM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.